BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang Y, Hu C. NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma. Dis Markers 2021;2021:5031479. [PMID: 34336003 DOI: 10.1155/2021/5031479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma C, Li F, Wang Z, Luo H, Suda K. A Novel Immune-Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma. BioMed Research International 2022;2022:1-16. [DOI: 10.1155/2022/4995874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Qi X, Liu P, Wang Y, Xue J, An Y, Zhao C. Insights Into the Research Status of Neuromedin U: A Bibliometric and Visual Analysis From 1987 to 2021. Front Med (Lausanne) 2022;9:773000. [PMID: 35273971 DOI: 10.3389/fmed.2022.773000] [Reference Citation Analysis]